McKesson Corp. (MCK)

150.50
1.80 1.21
NYSE : Distribution Services
Prev Close 148.70
Open 148.23
Day Low/High 148.06 / 152.04
52 Wk Low/High 133.82 / 178.86
Volume 1.72M
Avg Volume 1.85M
Exchange NYSE
Shares Outstanding 206.34M
Market Cap 30.75B
EPS 23.40
P/E Ratio 6.78
Div & Yield 1.36 (0.83%)

Latest News

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

Medical Supply Stocks Get Hit in Latest Example of the 'Amazon Effect'

In the last two weeks alone, three sectors have gotten hammered on announcements or reports about Amazon's plans.

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

As lawsuits tied to the opioid crisis keep piling up, Purdue Pharma is discontinuing direct sales calls to doctors. Will other opioid makers follow suit?

Drug Supply Chain Stocks Dip After White House Recommendations on Drug Pricing

Drug Supply Chain Stocks Dip After White House Recommendations on Drug Pricing

The White House Council of Economic Advisers on Friday, Feb. 9, released a report on how the government can help bring down drug prices.

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.

McKesson Reports Fiscal 2018 Third-Quarter Results

McKesson Reports Fiscal 2018 Third-Quarter Results

McKesson Corporation (NYSE:MCK) today reported that revenues for the third quarter ended December 31, 2017, were $53.

Managed Care Stocks Thrashed on Amazon News but Could Be Buying Opportunity

Managed Care Stocks Thrashed on Amazon News but Could Be Buying Opportunity

The stocks of healthcare giants such as United, Cigna and Anthem tumbled Tuesday following news that Amazon, Berkshire Hathaway and JPMorgan have banded together on a healthcare initiative for their workers.

NYC Joins Cities, Counties and States In Bringing Opioid Lawsuit

NYC Joins Cities, Counties and States In Bringing Opioid Lawsuit

New York City sues Purdue Pharma, Teva Pharmaceutical, Allergan, Johnson and Johnson, Endo International, McKesson, AmerisourceBergen and Cardinal Health over how opioids have devastated the city and its services.

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.

Opioids Get Their Day In Washington, but Effort To Dump Medicaid Gets Spotlight

Opioids Get Their Day In Washington, but Effort To Dump Medicaid Gets Spotlight

As opioid crisis becomes more deadly, public hearings put the pain killers front and center. But in bitterly divided Washington one meeting is more about chopping Medicaid.

Jim Cramer: I Blame the Pajama Traders for This Selloff

Jim Cramer: I Blame the Pajama Traders for This Selloff

They make more irrational, stupid moves based on nothing than I ever thought possible.

Cramer: 5 Rules for Our Beast of a Bull Market

Cramer: 5 Rules for Our Beast of a Bull Market

It might look easy now, but it looked easy in 1999, too.

McKesson Becomes #134 Most Shorted S&P 500 Component, Replacing Textron

The most recent short interest data has been released for the 12/29/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

McKesson CEO: It's 'Nonsense' We Haven't Done Enough to Combat Opioid Crisis

McKesson CEO: It's 'Nonsense' We Haven't Done Enough to Combat Opioid Crisis

In the past few weeks, McKesson has been unhappily tied to stories about opioids, including coverage on TheStreet. At the JPMorgan Healthcare Conference, the company took its case to investors.

America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear

America's Opioid Crisis Looks a Lot Like Big Tobacco Spats of Yesteryear

The crisis could seemingly turn a number of companies on their heads much in the way that big tobacco suits of the late 1990s forever changed the tobacco industry.

A Controversial Pick of the Year for 2018

A Controversial Pick of the Year for 2018

Nothing breeds future investment success like buying in the face of negative headlines.

McKesson Corporation Fiscal 2018 Third Quarter Conference Call Scheduled For February 1, 2018

McKesson Corporation Fiscal 2018 Third Quarter Conference Call Scheduled For February 1, 2018

McKesson Corporation (NYSE:MCK) will release financial results for its third fiscal quarter ended December 31, 2017 on Thursday, February 1, 2018, prior to the opening of trading on the New York Stock Exchange.

McKesson Completes Acquisition Of RxCrossroads

McKesson Completes Acquisition Of RxCrossroads

McKesson Corporation (NYSE:MCK), a global leader in healthcare supply chain management solutions, announced today that it has completed the previously announced acquisition of RxCrossroads.

My Controversial Pick of the Year for 2018

My Controversial Pick of the Year for 2018

Nothing breeds future investment success like buying in the face of negative headlines.

The Best Dividend Aristocrats for 2018

The Best Dividend Aristocrats for 2018

The five best high yielding stocks at discounted prices.

The 5 Best 'Dividend Aristocrats' for 2018

The 5 Best 'Dividend Aristocrats' for 2018

The best high-yielding blue chips at discounted prices.

25 Stocks That Could Have a Terrible Start to 2018

25 Stocks That Could Have a Terrible Start to 2018

Schaeffer's came out with a list of 25 stocks that could struggle once the calendar flips next week.

McKesson Corporation To Present At The 36th Annual J.P. Morgan Healthcare Conference

McKesson Corporation To Present At The 36th Annual J.P. Morgan Healthcare Conference

McKesson Corporation (NYSE:MCK) today announced that John Hammergren, chairman and chief executive officer, will present at the 36 th Annual J.

Will McKesson's Opioid Issue Linger?

Will McKesson's Opioid Issue Linger?

Market is pricing the stock as if the side effects of this report will just go away.

McKesson Announces Departure Of James Beer, EVP And CFO; Appoints Internal Successor, Britt Vitalone; Reaffirms Fiscal 2018 Outlook

McKesson Announces Departure Of James Beer, EVP And CFO; Appoints Internal Successor, Britt Vitalone; Reaffirms Fiscal 2018 Outlook

McKesson Corporation (NYSE:MCK) today announced James Beer, executive vice president and chief financial officer, will be leaving the company to pursue a new opportunity.

Amazon Could Gain 20% by Entering Health Care

Amazon Could Gain 20% by Entering Health Care

Moving into higher-margin products could boost Amazon's gross margins by 1,000 basis points, one analyst contends.

McKesson Strengthens Its Portfolio Of Manufacturer Solutions With The Acquisition Of RxCrossroads

McKesson Strengthens Its Portfolio Of Manufacturer Solutions With The Acquisition Of RxCrossroads

McKesson Corporation (NYSE:MCK) today announced that it has signed a definitive agreement to purchase RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health...

Discovering a True Value

Discovering a True Value

Revenues, cash flow and EPS are higher than ever for Discovery Communications.

Big Opportunities to Buy Stocks Have Secretly Emerged

Big Opportunities to Buy Stocks Have Secretly Emerged

The stock market has had a wild week. Some interesting opportunities may have finally emerged.

TheStreet Quant Rating: C+ (Hold)